These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29689140)

  • 21. AACR Cancer Progress Report 2016.
    Davidson NE; Armstrong SA; Coussens LM; Cruz-Correa MR; DeBerardinis RJ; Doroshow JH; Foti M; Hwu P; Kensler TW; Morrow M; Mulligan CG; Pao W; Platz EA; Smith TJ; Willman CL
    Clin Cancer Res; 2016 Oct; 22 Suppl 19():S1-S137. PubMed ID: 27697776
    [No Abstract]   [Full Text] [Related]  

  • 22. Targeted immunotherapies overtaking emerging oncology market value based growth.
    Jakovljevic MB
    J BUON; 2015; 20(1):350-1. PubMed ID: 25778340
    [No Abstract]   [Full Text] [Related]  

  • 23. Innovative oncology products: time to revisit the strategy development?
    Krendyukov A
    ESMO Open; 2019; 4(5):e000571. PubMed ID: 31749992
    [No Abstract]   [Full Text] [Related]  

  • 24. To all involved - we have a problem.
    Romero D
    Nat Rev Clin Oncol; 2018 Jul; 15(7):397. PubMed ID: 29880897
    [No Abstract]   [Full Text] [Related]  

  • 25. Combination therapies in oncology.
    Webster RM
    Nat Rev Drug Discov; 2016 Feb; 15(2):81-2. PubMed ID: 26837588
    [No Abstract]   [Full Text] [Related]  

  • 26. Cancer Therapy: Shooting for the Moon.
    Lee J; Blumenthal GM; Hohl RJ; Huang SM
    Clin Pharmacol Ther; 2017 May; 101(5):552-558. PubMed ID: 28418166
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial (Thematic Issue: Clinical Advances in Immuno-oncology - Progress Towards Selective Cure).
    Liu X; Belani CP
    Curr Mol Pharmacol; 2016; 9(3):182. PubMed ID: 26177639
    [No Abstract]   [Full Text] [Related]  

  • 28. [Oncology 1999: advances in immunotherapy].
    Cerny T
    Schweiz Med Wochenschr; 2000 Jan; 130(1-2):21-4. PubMed ID: 10670041
    [No Abstract]   [Full Text] [Related]  

  • 29. Forty-five years in oncology, 25 years with Acta Oncologica.
    Glimelius B
    Acta Oncol; 2018 Dec; 57(12):1593-1598. PubMed ID: 30489167
    [No Abstract]   [Full Text] [Related]  

  • 30. Optimism after much pessimism: what next?
    Milstein C; Waldmann H
    Curr Opin Immunol; 1999 Oct; 11(5):589-91. PubMed ID: 10508713
    [No Abstract]   [Full Text] [Related]  

  • 31. ASCO 2016 - Immuntherapie bringt weitere Fortschritte bei Hautkrebs.
    Oncol Res Treat; 2016; 39(11):728-731. PubMed ID: 27855384
    [No Abstract]   [Full Text] [Related]  

  • 32. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
    Golan T; Milella M; Ackerstein A; Berger R
    J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biotherapy of cancer. Perspectives of immunotherapy and gene therapy.
    Schirrmacher V
    J Cancer Res Clin Oncol; 1995; 121(8):443-51. PubMed ID: 7642685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The future of oncology therapeutics.
    Mansinho A; Boni V; de Miguel M; Calvo E
    Expert Rev Anticancer Ther; 2017 Jul; 17(7):563-565. PubMed ID: 28504011
    [No Abstract]   [Full Text] [Related]  

  • 35. What's new in surgery for 1991? Surgical oncology.
    Roth JA
    Bull Am Coll Surg; 1991 Jan; 76(1):30-3. PubMed ID: 10170668
    [No Abstract]   [Full Text] [Related]  

  • 36. Thomas Lynch.
    Nat Rev Drug Discov; 2017 Apr; 16(5):308. PubMed ID: 28450715
    [No Abstract]   [Full Text] [Related]  

  • 37. Awaiting a new era of cancer immunotherapy.
    Hong CW; Zeng Q
    Cancer Res; 2012 Aug; 72(15):3715-9. PubMed ID: 22815525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vision and will: the future of the FDA.
    Epstein D
    Oncologist; 2009 Apr; 14(4):317-9. PubMed ID: 19365098
    [No Abstract]   [Full Text] [Related]  

  • 39. The future of neuro-oncology.
    Piepmeier JM
    Acta Neurochir (Wien); 2009 Nov; 151(11):1343-8. PubMed ID: 19639245
    [No Abstract]   [Full Text] [Related]  

  • 40. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.
    Nelson B
    Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.